Published in Drug Week, April 28th, 2006
Under the agreement, taking advantage of Oakwood's microsphere-based technology platform (Chroniject), they will develop processing technology and a sustained release system for DE-102.
Diabetic macular edema is an ophthalmic disorder associated with swelling of the retina in diabetes mellitus due to leaking of fluid from blood vessels within the macula, which is in the central portion...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.